HCA Holdings guidance appears conservative, says Wells Fargo After HCA increased its full-year EBITDA guidance, Wells Fargo thinks the revised guidance is probably too conservative. The firm raised its price target on the shares to $68-$78 from $52-$60. It keeps an Outperform rating on the shares.
News For HCA From The Last 14 Days
Check below for free stories on HCA the last two weeks.